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of the profession in deciding how drugs
were to be evaluated.
If the ideal of a profession united by
science fell by the wayside, so too did
another key element of reform ideology; the
trust placed in the high moral character of
individual clinicians to ensure the integrity
of observations on the therapeutic effects of
drugs. Marks argues that during and after
the Second World War this trust began to
fade. It was replaced at the urging of
statisticians and others, with a reliance on
formal statistical methods-notably the
double-blind, randomized, controlled
clinical trial as means of assessing and
improving therapeutic knowledge. A faith in
method as the motor of reform superseded
a faith in the moral qualities of individuals.
Marks is not the first to trace a shift from a
trust in people to a trust in numbers, but
his may be the strongest historical voice
arguing for the incompleteness of this
change. As advocates of clinical trials
constantly remind us today, the clinical trial
has not permeated all areas of medical
research, and most therapeutic practices
have not been subject to the probe of a
trial. It is also true that experts disagree on
the value ofparticular designs for clinical
trials, and on how to explain results.
This then is the story of an incomplete
revolution. It is grounded in detailed case
studies: (before the Second World War) the
Cooperative Clinical Group's study of
syphilis treatments, and the Commonwealth
Fund's experiment with serum treatment for
pneumonia; (during and after the War) the
National Research Council's penicillin
investigations, and the Veteran
Administration/Public Health Service
investigations of streptomycin; and (in the
1960s) the National Institutes of Health
planned Diet-Heart Study, and the
University Group Diabetes Program study
of tolbutamide. Together these examples
help to flesh out the story of this partial
revolution. They also provide an insight
into the tensions between researchers and
general practitioners, and the impact of
patient compliance on experimental design.
It is possible to quibble that the story tells
us less than we might wish to know about
the nuts-and-bolts of therapeutic testing,
and that Marks' assertion that this is a
quintessentially American tale lacks a
comparative perspective to nail the point
home. These caveats aside, Marks has
produced an important account of
twentieth-century clinical medicine;
conceptually sophisticated, and supported
by a rich lode of footnotes. The cheaper
edition of this book will ensure that future
students can afford to mine the latter at
their leisure.
David Cantor,
National Cancer Institute, Bethesda
David Dranove, The economic evolution of
American health care:from Marcus Welby to
managed care, Princeton University Press,
2000, pp. 211, $27.95 (hardback 0-691-
00693-8).
This is an economist's study of rapid
change in a trillion-dollar industry-the
healthcare business in the USA. It traces
the evolution of medical care during the
twentieth century from the traditional
doctor (as represented in the 1960s
American TV show, Marcus Welby, MD) to
the present-day managed care organization.
For the British reader, all too familiar with
the shortcomings as well as the advantages
of the National Health Service, this study of
the merits and demerits of injecting business
principles into health care is interesting and
thought-provoking. However, the author's
predilection for acronyms makes it a less
than accessible read.
Under traditional health care, David
Dranove argues that individual patients
trusted in their doctor's professional
disinterestedness, clinical competence, and
ability to co-ordinate medical services.
Physicians also had loyalty to their patients,
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adequate remuneration and professional
autonomy. Unfortunately, the economic cost
of these idealized features became too high.
Health care costs as a percentage of
America's gross domestic product rose from
5.2 per cent in the 1950s to a peak of 13.7
per cent in 1993. This came about because
of a combination of general factors found
in many western countries (including an
ageing population, and innovation in
medical technology), with ones more specific
to the USA (such as hospital cost inflation,
patient-driven insurance and personnel
shortages).
Since 1993 managed care organizations
have grown rapidly to cover four-fifths of
the American working population.
Containment of health care costs has been
achieved, but this has been offset by related
disadvantages. The de-personalized
character of managed care has still to win
the trust of American patients, and to
overcome their suspicion that cost reduction
has compromised the quality ofcare. A
recent bout of merger mania amongst
providers has also reduced patients' choices,
but seemingly without significantly
increasing their efficiency. The author
concludes that better data on providers'
costs, and clinical outcomes, are needed
before this will show improvement. What is
termed "the shopping problem"-which
health care option the consumer should
choose still operates in managed care as it
did earlier in traditional medicine. Dranove
is intolerant ofpatients' poor knowledge
base and their ignorance of the rankings of
managed care organizations. He argues that
this means that not only do patients get a
less than optimal outcome, but that the
efficiency and effectiveness ofmanaged care
organizations remain unimproved. One
reason for what the author terms the "wilful
indifference" of consumers (p. 168), and
their ab,dication of responsibility in
choosing health care options, is the
intricacy ofmanaged care.
American managed health care involves
different kinds ofnon-profit and with-profit
businesses that range from prepaid group
practices to indemnity insurance firms. The
author's well-balanced and up-to-date
review of the data on their efficiency and
effectiveness shows their ambiguous and
complex character. There appear to be no
easy answers and quick fixes in the policy
options for health care reform.
Anne Digby,
Oxford Brookes University
Gary Taylor, Castration: an abbreviated
history ofwestern manhood, New York and
London, Routledge, 2000, pp. 307, £15.99
(hardback 0-415-92785-4).
The main thrust behind Gary Taylor's
eclectic history ofwestern manhood is that
if we are to understand what a man is, it
helps to reflect on what a man is not; in
other words, eunuchs, or castrated men, can
tell us a lot about what masculinity means
throughout western culture and history. But
which authority should one ask about
castration and masculinity? Sigmund Freud?
Saint Augustine? Jesus? Seventeenth-century
English playwright, Thomas Middleton? A
priest in the ancient Roman cult of Cybele
(whose acolytes castrated themselves)? Pop-
star, Tory Amos? In Castration, the answer
is all of them, but especially Freud,
Middleton, Jesus and Augustine. The point
is that different meanings ofmasculinity are
attached in some way to castration,
depending on the field being considered.
Thus, Taylor locates some important re-
articulations of these ideas, as well as what
he treats as atemporal or fundamental
aspects ofmasculinity. They come together
to give us a good story indeed.
In a post-Freudian world, kastrationangst
is a significant part of a young boy's
development. Other male anxieties include
sexual redundancy, when women as
experienced by Taylor-do not want sex-
for-reproduction as much as sex-for-
pleasure (and one does not need testicles for
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